SHL Medical secures financial support for drug delivery growth strategy

SHL Medical has secured financial support from a consortium of investors including EQT Future and ATHOS to execute its 2030 growth strategy, which includes adding production capacity in the U.S. and Europe. The company previously announced plans to invest $90 million in a new manufacturing plant in South Carolina, due to start operations in 2024.

“SHL Medical has secured financial support for the next phase of its drug delivery growth plan, bringing on board a consortium of investors that will enable it to add production capacity in the U.S. and Europe.”fiercepharma.com

• 1 source
• fiercepharma.comSHL lands financial support for drug delivery growth strategyNick Paul TaylorDec 13, 2022

Summarized from public sources; check the original articles before acting on it.